BancorpSouth’s PDL BioPharma, Inc. PDLI Stock Holding History

BancorpSouth’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	$74K	Hold	21,800	–	–	0.01%	250
2017 Q2	$54K	Hold	21,800	–	–	0.01%	235
2017 Q1	$49K	Hold	21,800	–	–	0.01%	239
2016 Q4	$46K	Hold	21,800	–	–	0.01%	229
2016 Q3	$73K	Hold	21,800	–	–	0.01%	247
2016 Q2	$68K	Hold	21,800	–	–	0.01%	243
2016 Q1	$73K	Hold	21,800	–	–	0.01%	251
2015 Q4	$77K	Hold	21,800	–	–	0.01%	240
2015 Q3	$110K	Hold	21,800	–	–	0.01%	226
2015 Q2	$140K	Hold	21,800	–	–	0.02%	244
2015 Q1	$153K	Hold	21,800	–	–	0.02%	251
2014 Q4	$168K	Sell	21,800 -66	-0.3%	-$522	0.02%	250
2014 Q3	$163K	Hold	21,866	–	–	0.02%	267
2014 Q2	$212K	Buy	21,866 +66	+0.3%	+$588	0.02%	255
2014 Q1	$181K	Hold	21,800	–	–	0.02%	241
2013 Q4	$184K	Hold	21,800	–	–	0.02%	241
2013 Q3	$174K	Hold	21,800	–	–	0.02%	226
2013 Q2	$168K	Buy	+21,800	New	+$170K	0.02%	208

Other funds holding PDLI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BancorpSouth's PDLI Position: Q3 2017 in Review

BancorpSouth held its PDL BioPharma, Inc. (PDLI) position steady in Q3 2017 at 21,800 shares worth $74K. The position accounts for 0.01% of the portfolio, ranked #250.

BancorpSouth first reported a position in PDLI in Q2 2013 and has held it in 18 quarters since. The position peaked at $212K in Q2 2014. 186 funds tracked by Wall St. Rank hold PDLI as of Q3 2017.

BancorpSouth held 21,800 shares of PDL BioPharma, Inc. worth $74K as of Q3 2017.
BancorpSouth left its PDL BioPharma, Inc. share count unchanged in Q3 2017.
PDL BioPharma, Inc. made up 0.01% of BancorpSouth's portfolio in Q3 2017, its #250 holding.
BancorpSouth first reported a position in PDL BioPharma, Inc. in Q2 2013 and has held it in 18 quarters since.
BancorpSouth's PDL BioPharma, Inc. position peaked at $212K in Q2 2014.
186 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q3 2017.

Based on BancorpSouth's 13F filing for Q3 2017, filed 14 Nov 2017.